
Edap Tms S.A. (($FOCL)) has held its Q3 earnings call. Read on for the main highlights of the call. EDAP TMS delivered a largely positive third quarter, supported by 26%
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| FOCL | FocalTherics | 2.61 | 0.31 | 13.48% |
| Name | Price | % Change | |
|---|---|---|---|
| $2.61 | +13.48% |

Edap Tms S.A. (($FOCL)) has held its Q3 earnings call. Read on for the main highlights of the call. EDAP TMS delivered a largely positive third quarter, supported by 26%

Lucid Capital lowered the firm’s price target on FocalTherics (FOCL) to $8 from $10 and keeps a Buy rating on the shares following the Q3 report. Published first on TheFly

Reports Q3 revenue $9.83M, consensus $11.51M. “We demonstrated steady commercial momentum in the third quarter, highlighted by expanding adoption across multiple new regions and additional system sales in the United

Consensus $52M. The company said, “We are narrowing our full-year 2026 revenue guidance to be in the range of $50.0 to $52.0 million, representing 34% to 39% growth over 2025,

Analyst Swayampakula Ramakanth of H.C. Wainwright maintained a Buy rating on FocalTherics, retaining the price target of $10.00. Swayampakula Ramakanth’s rating is based on several factors, including expected HIFU revenue

Edap Tms S.A. (FOCL) is scheduled to report 3rd quarter earnings on 11/05/2026, after the market closes. Regarding Q3 estimates, Wall Street analysts expect Edap Tms S.A. to post earnings

Analyst Swayampakula Ramakanth of H.C. Wainwright maintained a Buy rating on FocalTherics, retaining the price target of $10.00. Swayampakula Ramakanth has given his Buy rating due to a combination of

Edap Tms S.A. (($FOCL)) has held its Q2 earnings call. Read on for the main highlights of the call. Edap TMS S.A.’s latest earnings call struck a notably upbeat tone,

FocalTherics ( ($FOCL) ) has shared an announcement. On August 11, 2026, EDAP TMS S.A. entered into an underwriting agreement with TD Securities (USA) LLC and Mizuho Securities USA LLC

FocalTherics (FOCL) announced that it has commenced an underwritten public offering of American depositary shares. All of the ADSs in the proposed offering will be sold by the company. The
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Mar 31, 2027TBA | $133.16M | $-0.19 | $16.22M | -0.10 | -2.66 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.